NASDAQ:MRVI

Maravai LifeSciences News Headlines

$36.68
+0.05 (+0.14 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$36.24
Now: $36.68
$37.16
50-Day Range
$32.03
MA: $34.95
$38.49
52-Week Range
$23.62
Now: $36.68
$40.24
Volume750,861 shs
Average Volume1.48 million shs
Market Capitalization$9.45 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Maravai LifeSciences (NASDAQ MRVI) News Headlines Today

SourceHeadline
Zacks Investment Research Lowers Maravai LifeSciences (NASDAQ:MRVI) to HoldZacks Investment Research Lowers Maravai LifeSciences (NASDAQ:MRVI) to Hold
marketbeat.com - April 8 at 1:39 AM
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional SharesMaravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 12 at 6:53 PM
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 4.8%Maravai LifeSciences (NASDAQ:MRVI) Trading Up 4.8%
americanbankingnews.com - April 9 at 12:32 PM
Maravai LifeSciences (NASDAQ:MRVI) Sees Unusually-High Trading VolumeMaravai LifeSciences (NASDAQ:MRVI) Sees Unusually-High Trading Volume
americanbankingnews.com - April 8 at 11:50 AM
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling StockholdersMaravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
finance.yahoo.com - April 7 at 10:47 PM
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling StockholdersMaravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
benzinga.com - April 7 at 7:46 AM
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down to $34.58Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down to $34.58
americanbankingnews.com - April 6 at 11:02 AM
Maravai’s 1Q Revenue Outlook Misses Estimates; Street Sees Over 34% UpsideMaravai’s 1Q Revenue Outlook Misses Estimates; Street Sees Over 34% Upside
finance.yahoo.com - April 6 at 9:42 AM
Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations RangeMaravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
finance.yahoo.com - April 5 at 6:08 PM
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling StockholdersMaravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
finance.yahoo.com - April 5 at 6:08 PM
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies Plasmid DNA Manufacturing ServicesMaravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
finance.yahoo.com - March 15 at 8:58 AM
New Forecasts: Heres What Analysts Think The Future Holds For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)New Forecasts: Here's What Analysts Think The Future Holds For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
nasdaq.com - March 10 at 8:40 AM
Maravai LifeSciences (NASDAQ:MRVI) PT Raised to $46.00 at KeyCorpMaravai LifeSciences (NASDAQ:MRVI) PT Raised to $46.00 at KeyCorp
americanbankingnews.com - March 9 at 8:38 AM
Analysts Just Made A Dazzling Upgrade To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) ForecastsAnalysts Just Made A Dazzling Upgrade To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Forecasts
finance.yahoo.com - March 7 at 12:35 PM
Stock Alert: Maravai LifeSciences Up 12% After Swinging To Profit In Q4Stock Alert: Maravai LifeSciences Up 12% After Swinging To Profit In Q4
nasdaq.com - March 3 at 1:59 PM
Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 2020 Earnings Call TranscriptMaravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 3 at 1:58 PM
Maravai LifeSciences Swings To Q4 Profit, Shares Up 20%Maravai LifeSciences Swings To Q4 Profit, Shares Up 20%
nasdaq.com - March 2 at 7:11 PM
Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial GuidanceMaravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
finance.yahoo.com - March 2 at 7:11 PM
Maravai LifeSciences Announces March 2021 Investor Conference ScheduleMaravai LifeSciences Announces March 2021 Investor Conference Schedule
finance.yahoo.com - March 1 at 8:50 AM
Maravai LifeSciences Holdings, Inc.s (NASDAQ:MRVI) About To Shift From Loss To ProfitMaravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) About To Shift From Loss To Profit
finance.yahoo.com - February 22 at 2:41 PM
MRVI Mar 2021 40.000 putMRVI Mar 2021 40.000 put
ca.finance.yahoo.com - February 13 at 11:46 PM
Maravai LifeSciences Expands Its Intellectual Property PortfolioMaravai LifeSciences Expands Its Intellectual Property Portfolio
finance.yahoo.com - February 10 at 7:23 AM
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
finance.yahoo.com - January 28 at 7:09 PM
Maravai Lifesciences Holdings IncMaravai Lifesciences Holdings Inc
uk.reuters.com - December 18 at 11:13 PM
Maravai LifeSciences Holdings Inc.Maravai LifeSciences Holdings Inc.
wsj.com - December 17 at 10:10 PM
Sotera Health IPO Prices At High End Of Range; Shares SurgeSotera Health IPO Prices At High End Of Range; Shares Surge
finance.yahoo.com - December 4 at 4:03 AM
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesMaravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 4 at 4:03 AM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.